Daily US Times: President Joe Biden’s Covid vaccination campaign hit a snag when federal regulators recommended a “pause” in the rollout of Johnson & Johnson shots. But the White House officials portrayed the action as an important validation of his measured approach throughout the vaccine rollout.
On Tuesday, President Biden declared that even with a temporary loss of J&J ’s one-shot vaccine, there is a huge supply of Moderna and Pfizer vaccines, enough that “is basically 100% unquestionable, for every single, solitary American.”
However, perhaps more concerning than any worry about supply is the potential blow to public confidence in all of the Covid-19 vaccines, as polls suggest potentially tens of millions of Americans are hesitant to get the vaccines that public health experts say are necessary for the nation to emerge from the coronavirus pandemic.
The pause of the J&J shots actually should have the opposite effect, boosting confidence that the government is putting safety first, Joe Biden and top health officials said at a White House briefing.
The advisory by the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) — citing a need to investigate reports of rare but potentially dangerous blood clots — was “testimony to how seriously we take safety,” said Dr. Anthony Fauci, top US infectious disease expert.
In the opening months of his presidency, Joe Biden has put top priority on a robust response to the coronavirus that has killed 559,000 Americans, a world high, with a vaccine campaign in which nearly 50% of adults have received at least one shot.
You may read: Johnson & Johnson vaccine paused over rare blood clots